|
|
() / IBRANCE (palbociclib) |
|
/
/ () / IBRANCE (palbociclib)
HR+/HER2, 70% .
, .
-
-
--
-
() / IBRANCE (palbociclib) . / , , . , , .
:
|
. / 30 .
Ferrer Internacional
|
|
|
|
. / 125 / 30 .
|
|
|
|
80 , 10 / 1 .
Qixing
|
|
|
|
. 100 / 50 .
|
|
|
|
. 100 / 21 .
Pfizer Inc.
|
405771 .
|
! |
|
|
|
|
|
. 90 / 1 .
Herbion Pakistan
|
|
|
|
. . / 30 .
Ferrer Internacional
|
|
|
|
300 , . / 1 .
|
|
|
|
. / 125 / 30 .
-
|
|
|
|
. . / - /. 61 ., . . 2 / 3 .
Ferrer Internacional
|
4560 .
|
! |
|
|
|
|
|
. . / 20 .
|
|
|
|
. . / 40 .
|
|
|
|
. / 40 .
|
|
|
|
- / 10 / 10 .
|
|
|
|
. / / 50 .
|
|
|
|
/. . . 30 / 1 .
Beres
|
|
|
|
. / 30 .
Beres
|
|
|
|
. 20+50+60 / 30 .
Nycomed
|
|
|
|
. 2 / 5 .
Nycomed
|
|
|
|
. 60+100+60 / 50 .
Nycomed
|
|
|
|
. / 20 .
Herbion Pakistan
|
|
|
|
- /. 50 / . 5 5% / 5 .
|
|
|
|
- /. 50 / . 2 5% / 10 .
|
|
|
|
. / 125 / 50 .
|
|
|
|
- /. 50 / . 2 / 10 .
-
|
|
|
|
- /. 5 % . 2 / 10 .
|
|
|
|
. 10 / 1 .
|
1415 .
|
! |
|
|
|
|
|
/ 200 .
Lanzhou Foci Ph. Company
|
|
|
|
|
